Hawkins, Inc.

HWKN

US4202611095

Diversified Chemicals

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
78.23 ^USD	+3.23%		+2.99%	+11.09%

Apr. 17	ReNeuron Group Reports CFO Resignation	MT
Apr. 17	ReNeuron CFO steps down to pursue other opportunities	AN

ReNeuron CFO steps down to pursue other opportunities

April 17, 2024 at 07:00 am EDT

(Alliance News) - ReNeuron Group PLC on Wednesday announced Chief Financial Officer John Hawkins will be stepping down from his role on May 7.

Hawkins will be leaving the Brigdend, Wales-based stem cell and exosomes technology company to pursue other opportunities.

However, he will continue to provide his support to the firm during the ongoing administration process, ReNeuron said.

Hawkins first joined the firm in 2014 as chief financial controller. He was then promoted to CFO in September 2022.

Shares in ReNeuron were untraded at 3.28 pence each in London on Wednesday morning.

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	HAWKINS, INC.	78.23 USD	+3.23%	+2.99%	1.64B
	RENEURON GROUP PLC	3.375 GBX	-2.17%	-.--%	2.42M

Latest news about Hawkins, Inc.

ReNeuron Group Reports CFO Resignation	Apr. 17	MT
ReNeuron CFO steps down to pursue other opportunities	Apr. 17	AN
March Industrial Production Rises In Line With Expectations, Fed Says	Apr. 16	MT
JELD-WEN to Close Two Manufacturing Facilities	Apr. 11	MT
Arthur J. Gallagher Acquires Specialty Risk Management Services and Private Client Insurance Services	Apr. 01	MT
February Industrial Production Unexpectedly Rises as Manufacturing Rebounds	Mar. 15	MT
Hawkins Completes Industrial Research Acquisition	Mar. 11	MT
Hawkins, Inc. acquired Industrial Research Corporation.	Mar. 10	CI
January Wholesale Costs Rise More Than Expected	Feb. 16	MT
IAG's Fiscal First-Half Net Profit Slips; Price Increase Boosts Insurance Profit	Feb. 16	MT
Santos investors divided as activist resumes campaign for LNG spin-off	Feb. 08	RE
Hawkins Fiscal Q3 Earnings Rise, Sales Fall; Shares Drop After Hours	Jan. 31	MT
Hawkins, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 31	CI
Earnings Flash (HWKN) HAWKINS Posts Q3 Revenue $208.5M, vs. Street Est of $221.2M	Jan. 31	MT
Hawkins, Inc. Increases Quarterly Cash Dividend, Payable on March 1, 2024	Jan. 31	CI
Zurich Insurance's sale of $20bn German life insurance book falls through	Jan. 30	RE
December Consumer Spending Accelerates, Annual Core Inflation Drops Below 3%	Jan. 26	MT
Houthis order US, British nationals to leave Yemen	Jan. 24	RE
Correction: December Housing Starts Snap Three-Month Building Streak, Permits Rise	Jan. 18	MT
December Housing Starts Snap Four-Month Building Streak, Permits Rise	Jan. 18	MT
December Services Sector Growth Slows More Than Expected, ISM Survey Shows	Jan. 05	MT
Equities Slip as Traders Parse FOMC Minutes, Richmond Fed President Comments	Jan. 03	MT
Equity Markets Fall Intraday as Traders Weigh Macro Data	Jan. 03	MT
Manufacturing Contraction Recovers More Than Expected in December, ISM Survey Shows	Jan. 03	MT
Equities Slip as Traders Parse FOMC Minutes, Richmond Fed President Comments	Jan. 03	MT

Hawkins, Inc. is a specialty chemical and ingredients company that formulates, distributes, blends and manufactures products for its customers. The Company operates through three segments: Industrial, Water Treatment, and Health and Nutrition. Its Industrial segment specializes in providing industrial chemicals, products and services to industries such as agriculture, chemical processing, electronics, energy, food, pharmaceutical and plating. The Water Treatment segment specializes in providing chemicals, equipment and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water and agricultural water. The Health and Nutrition segment specializes in providing ingredient distribution, processing and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, health and wellness products.

Sector

Diversified Chemicals

Calendar

2024-05-14 - Q4 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Hawkins, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

78.23 USD

Average target price

74 USD

Spread / Average Target

-5.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Diversified Chemicals

	1st Jan change	Capi.
HAWKINS, INC.	+11.09%	1.64B
SHIN-ETSU CHEMICAL CO., LTD.	+4.70%	75.24B
BASF SE	+0.56%	46.91B
DUPONT DE NEMOURS, INC.	-3.94%	30.9B
PIDILITE INDUSTRIES LIMITED	+11.97%	18.41B
BRENNTAG SE	-9.54%	11.65B
EASTMAN CHEMICAL COMPANY	+8.37%	11.45B
SYENSQO SA/NV	-7.33%	9.85B
ASAHI KASEI CORPORATION	+5.92%	9.45B
SRF LIMITED	+6.58%	9.37B

Diversified Chemicals

Hawkins, Inc.

Equities

HWKN

US4202611095

Diversified Chemicals

ReNeuron CFO steps down to pursue other opportunities

Stocks mentioned in the article

Latest news about Hawkins, Inc.

Chart Hawkins, Inc.

Company Profile

Income Statement Evolution

Ratings for Hawkins, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diversified Chemicals